Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models
Takuya Kato, Ryuhei Okada, Aki Furusawa, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 11, pp. 2262-2273
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy
T. M. Mohiuddin, Chaoyu Zhang, Wenjie Sheng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2655-2655
Open Access | Times Cited: 32
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy
Hiroaki Wakiyama, Takuya Kato, Aki Furusawa, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 11, pp. 1386-1397
Open Access | Times Cited: 34
PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer
Kento Kawasaki, Kazuhiro Noma, Takuya Kato, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3787-3802
Open Access | Times Cited: 18
Near-infrared Photoimmunotherapy: mechanisms, applications, and future perspectives in cancer research
Donald O. Allen, Madeline JoAnna Szoo, Tessa D. van Bergen, et al.
Antibody Therapeutics (2025) Vol. 8, Iss. 1, pp. 68-85
Open Access
CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model
Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 21
The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations
Michihisa Kono, Shin Saito, Ann Marie Egloff, et al.
Oral Oncology (2022) Vol. 132, pp. 106012-106012
Open Access | Times Cited: 21
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Isis Wolf, Susanne Schultze-Seemann, C. Gratzke, et al.
Antibodies (2025) Vol. 14, Iss. 1, pp. 5-5
Open Access
Carbonic anhydrase‐9‐targeted near‐infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma
Hiroshi Fukushima, Seiichiro Takao, Aki Furusawa, et al.
International Journal of Cancer (2025)
Open Access
Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
Takuya Kato, Hiroshi Fukushima, Aki Furusawa, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 18
Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer
Hiroshi Fukushima, Takuya Kato, Aki Furusawa, et al.
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3180-3192
Open Access | Times Cited: 16
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts
Takuya Kato, Aki Furusawa, Ryuhei Okada, et al.
Molecular Cancer Therapeutics (2022) Vol. 22, Iss. 1, pp. 75-88
Open Access | Times Cited: 16
Tumor‐associated genetic amplifications impact extracellular vesicle miRNA cargo and their recruitment of nerves in head and neck cancer
Anthony Restaino, Austin Walz, Sarah M. Barclay, et al.
The FASEB Journal (2024) Vol. 38, Iss. 13
Open Access | Times Cited: 3
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
Hiroshi Fukushima, Barış Türkbey, Peter A. Pinto, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2996-2996
Open Access | Times Cited: 15
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy
Ryuhei Okada, Takuya Kato, Aki Furusawa, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 8, pp. 1877-1887
Open Access | Times Cited: 14
Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy
Hiroshi Fukushima, Aki Furusawa, Takuya Kato, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 10, pp. 1215-1227
Closed Access | Times Cited: 8
Translational research in head and neck cancer: Molecular and immunological updates
Takumi Kumai, Hirotaka Shinomiya, Hirofumi Shibata, et al.
Auris Nasus Larynx (2023) Vol. 51, Iss. 2, pp. 391-400
Closed Access | Times Cited: 6
Near-Infrared Photoimmunotherapy for Thoracic Cancers: A Translational Perspective
Kohei Matsuoka, Mizuki Yamada, Mitsuo Sato, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1662-1662
Open Access | Times Cited: 10
Near-infrared photoimmunotherapy and anti-cancer immunity
Kohei Nakajima, Mikako Ogawa
International Immunology (2023) Vol. 36, Iss. 2, pp. 57-64
Open Access | Times Cited: 5
Antitumor host immunity enhanced by near‐infrared photoimmunotherapy
Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, et al.
Cancer Science (2024)
Open Access | Times Cited: 1
Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts
Hideyuki Furumoto, Takuya Kato, Hiroaki Wakiyama, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 846-846
Open Access | Times Cited: 5
Comparison of the Effectiveness of IgG Antibody versus F(ab′)2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy
Takuya Kato, Ryuhei Okada, Aki Furusawa, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 10, pp. 3600-3611
Open Access | Times Cited: 5
NIR-PIT: Will it become a standard cancer treatment?
Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment
Yudai Kaneko, Kenzo Yamatsugu, Takefumi Yamashita, et al.
Cancer Science (2022) Vol. 113, Iss. 12, pp. 4350-4362
Open Access | Times Cited: 3
Distinct Sulfated Glycans Expressed in Intrahepatic Cholangiocarcinoma: A Potential Target for New Therapy
Hitomi Hoshino, Motohiro Kobayashi
Immunotherapy (2023) Vol. 15, Iss. 7, pp. 503-516
Closed Access | Times Cited: 1
PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome
Kento Kawasaki, Kazuhiro Noma, Takuya Kato, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top